Teva to buy German drugmaker Ratiopharm

Associated Press via Yahoo

Israeli drugmaker Teva has beaten out rivals Pfizer and Actavis to acquire German generic drugmaker Ratiopharm GmbH in a deal announced Thursday worth nearly $5 billion.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
money arrows decrease down 2.png
Texas declares Friday Health Plans insolvent, seizes assets
stephanie-rhee-Klrz1qOKPAc-unsplash.jpg
Walgreens bets big on VillageMD as it expands healthcare services
Most Popular
1
More healthcare organizations at risk of credit default, Moody's says
2
Centene fills out senior executive team with new president, COO
3
SCAN, CareOregon plan to merge into the HealthRight Group
4
Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
5
Bright Health weighs reverse stock split as delisting looms